NEW YORK, Nov. 16, 2016 /PRNewswire/ -- The global market for life sciences and analytical instruments increased from $34.80 billion in 2016 to $48.48 billion by 2021. The last 5-6 years have been predominantly eventful for instrument companies with major mergers and acquisitions, partnerships, new product launches, and other business developments. With rising government spending on pharmaceutical R&D in emerging nations, increasing life science research and development expenditure, progressing drug discovery and clinical diagnostics field, technological advancements, emerging applications, growing aging populations, rising prevalence of chronic diseases, and changing demographics;numerous industry participants reported record sales primarily driven by the robust growth in emerging countries such as China, India, and Brazil. The increase in number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and emergence of proteomics have enabled industry growth; as such high-end research projects require quality instruments with high throughput capacity are fueling the life Science and analytical instrumentation market further. However, presence of alternative technologies and high cost of instruments are some of the key factors hampering the growth of this market.The global life science and analytical instruments market is mainly segmented by product, end-user, and geography. Spectroscopy segment commanded the largest share in the global life science and analytical instruments market, followed by separation techniques such as liquid and gas chromatography. The comprehensive end-user analysis is provided in the report for each technology. The market is further segmented by geography into four major continents namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at a country level to provide the market size and forecast for each segment and sub-segment of the market in various countries across the globe. North America and Europe have been in the forefront of acknowledging the need for life science and analytical instruments in biopharmaceuticals and pharmaceuticals, followed by Asia-Pacific, Latin America, and Middle East & Africa.